×
About 7,230 results

ALLMedicine™ Acromegaly Center

Research & Reviews  3,445 results

THE PREVALENCE OF CANCER AND ITS RELATION TO DISEASE ACTIVITY IN PATIENTS WITH ACROMEGA...
https://doi.org/10.4158/EP-2020-0398
Endocrine Practice : Official Journal of the American Col... Ucan B, Kizilgul M et. al.

Jan 21st, 2021 - Acromegaly is characterized by increased serum concentrations of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Although animal studies have demonstrated a relationship between these hormones and cancer risk, the results of human st...

Medical Treatment Landscape for Active Acromegaly in A Pituitary Center in Israel.
https://doi.org/10.4158/EP-2020-0171
Endocrine Practice : Official Journal of the American Col... Masri-Iraqi H, Akirov A et. al.

Jan 20th, 2021 - To evaluate current real-life experience with medical treatment for active acromegaly in a large cohort. Data on demographic parameters, blood tests, imaging studies, and treatments were extracted from the medical records. The cohort included 87 p...

Evaluation of ocular hypoperfusion in patients with acromegaly by using optical coheren...
https://doi.org/10.1080/02713683.2021.1877311
Current Eye Research; Karahan M, Demirtaş AA et. al.

Jan 15th, 2021 - This study aimed to evaluate the retinal blood vessel parameters and the foveal avascular zone (FAZ) area using optical coherence tomography angiography (OCTA) in patients with acromegaly in comparison with healthy controls. A total of 45 patients...

Management of endocrine disease: Carney complex (CNC): clinical and genetic update twen...
https://doi.org/10.1530/EJE-20-1120
European Journal of Endocrinology; Bouys L, Bertherat J

Jan 14th, 2021 - Described for the first time in 1985, Carney complex (CNC) is a rare dominantly inherited multiple neoplasia syndrome with almost full penetrance, and characterized by both endocrine - primary pigmented nodular adrenocortical disease with Cushing'...

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799425
Advances in Therapy; Cella D, Evans J et. al.

Jan 12th, 2021 - Somatostatin analogs (SSAs) are used to treat neuroendocrine tumors (NETs) and acromegaly. Two first-generation SSAs, octreotide long-acting release (OCT LAR) and lanreotide autogel/depot (LAN), are available. A systematic literature review (SLR) ...

see more →

Guidelines  13 results

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) ...
https://doi.org/10.1016/j.numecd.2016.02.001
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Baroni MG, Giorgino F et. al.

Feb 25th, 2016 - Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic de...

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) ...
https://doi.org/10.1007/s40618-015-0404-6
Journal of Endocrinological Investigation; Baroni MG, Giorgino F et. al.

Dec 31st, 2015 - Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic de...

Acromegaly: an endocrine society clinical practice guideline.
https://doi.org/10.1210/jc.2014-2700
The Journal of Clinical Endocrinology and Metabolism; Katznelson L, Laws ER et. al.

Oct 30th, 2014 - The aim was to formulate clinical practice guidelines for acromegaly. The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), five experts in the field, and a methodologist. The authors received no...

Expert consensus document: A consensus on the medical treatment of acromegaly.
https://doi.org/10.1038/nrendo.2014.21
Nature Reviews. Endocrinology; Giustina A, Chanson P et. al.

Feb 25th, 2014 - In March 2013, the Acromegaly Consensus Group met to revise and update guidelines for the medical treatment of acromegaly. The meeting comprised experts skilled in the medical management of acromegaly. The group considered treatment goals covering...

American Association of Clinical Endocrinologists medical guidelines for clinical pract...
https://www.ncbi.nlm.nih.gov/pubmed/21846616
Endocrine Practice : Official Journal of the American Col... Katznelson L, Atkinson JL et. al.

Aug 23rd, 2011 - American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.|2011|Katznelson L,Atkinson JL,Cook DM,Ezzat SZ,Hamrahian AH,|diagnosis,therapy,standards,trends,...

see more →

Drugs  35 results see all →

Clinicaltrials.gov  3,605 results

THE PREVALENCE OF CANCER AND ITS RELATION TO DISEASE ACTIVITY IN PATIENTS WITH ACROMEGA...
https://doi.org/10.4158/EP-2020-0398
Endocrine Practice : Official Journal of the American Col... Ucan B, Kizilgul M et. al.

Jan 21st, 2021 - Acromegaly is characterized by increased serum concentrations of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Although animal studies have demonstrated a relationship between these hormones and cancer risk, the results of human st...

Medical Treatment Landscape for Active Acromegaly in A Pituitary Center in Israel.
https://doi.org/10.4158/EP-2020-0171
Endocrine Practice : Official Journal of the American Col... Masri-Iraqi H, Akirov A et. al.

Jan 20th, 2021 - To evaluate current real-life experience with medical treatment for active acromegaly in a large cohort. Data on demographic parameters, blood tests, imaging studies, and treatments were extracted from the medical records. The cohort included 87 p...

Evaluation of ocular hypoperfusion in patients with acromegaly by using optical coheren...
https://doi.org/10.1080/02713683.2021.1877311
Current Eye Research; Karahan M, Demirtaş AA et. al.

Jan 15th, 2021 - This study aimed to evaluate the retinal blood vessel parameters and the foveal avascular zone (FAZ) area using optical coherence tomography angiography (OCTA) in patients with acromegaly in comparison with healthy controls. A total of 45 patients...

Management of endocrine disease: Carney complex (CNC): clinical and genetic update twen...
https://doi.org/10.1530/EJE-20-1120
European Journal of Endocrinology; Bouys L, Bertherat J

Jan 14th, 2021 - Described for the first time in 1985, Carney complex (CNC) is a rare dominantly inherited multiple neoplasia syndrome with almost full penetrance, and characterized by both endocrine - primary pigmented nodular adrenocortical disease with Cushing'...

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799425
Advances in Therapy; Cella D, Evans J et. al.

Jan 12th, 2021 - Somatostatin analogs (SSAs) are used to treat neuroendocrine tumors (NETs) and acromegaly. Two first-generation SSAs, octreotide long-acting release (OCT LAR) and lanreotide autogel/depot (LAN), are available. A systematic literature review (SLR) ...

see more →

News  119 results

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_6

Sep 15th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_2

Sep 15th, 2020 - Causes of excess IGF-I action can be divided into the following three categories: Release of primary GH excess from the pituitary Increased GHRH secretion or hypothalamic dysregulation Hypothetically, the excessive production of IGF-binding protei...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763

Sep 15th, 2020 - Gigantism refers to abnormally high linear growth due to excessive action of insulin-like growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the gr...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_3

Sep 15th, 2020 - Gigantism is extremely rare, with approximately 100 reported cases to date. Acromegaly is more common than gigantism, with an incidence of 3-4 cases per million people per year and a prevalence of 60 cases per million population. A claims-based an...

FDA Approves First Oral Somatostatin Analog for Acromegaly
https://www.staging.medscape.com/viewarticle/933087

Jun 28th, 2020 - The US Food and Drug Administration (FDA) has approved oral octreotide (Mycapssa, Chiasma) delayed-release capsules for the long-term maintenance treatment of patients with acromegaly who previously responded to and tolerated octreotide or lanreot...

see more →

Patient Education  13 results see all →